| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 6906283
[patent_doc_number] => 20050101678
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-12
[patent_title] => 'Antibacterial composition'
[patent_app_type] => utility
[patent_app_number] => 10/657345
[patent_app_country] => US
[patent_app_date] => 2003-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5203
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0101/20050101678.pdf
[firstpage_image] =>[orig_patent_app_number] => 10657345
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/657345 | Antibacterial composition | Sep 7, 2003 | Abandoned |
Array
(
[id] => 1014695
[patent_doc_number] => 06894037
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-05-17
[patent_title] => '2-methylene-19-nor-20(S)-25-methyl-1α-hydroxycalciferol and its uses'
[patent_app_type] => utility
[patent_app_number] => 10/657533
[patent_app_country] => US
[patent_app_date] => 2003-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8237
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/894/06894037.pdf
[firstpage_image] =>[orig_patent_app_number] => 10657533
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/657533 | 2-methylene-19-nor-20(S)-25-methyl-1α-hydroxycalciferol and its uses | Sep 7, 2003 | Issued |
Array
(
[id] => 7084045
[patent_doc_number] => 20050049425
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-03
[patent_title] => 'Ethylenically-unsaturated red anthraquinone dyes'
[patent_app_type] => utility
[patent_app_number] => 10/647828
[patent_app_country] => US
[patent_app_date] => 2003-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6776
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0049/20050049425.pdf
[firstpage_image] =>[orig_patent_app_number] => 10647828
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/647828 | Ethylenically-unsaturated red anthraquinone dyes | Aug 24, 2003 | Issued |
Array
(
[id] => 1022063
[patent_doc_number] => 06887991
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-05-03
[patent_title] => 'Processes for preparation of 9, 11-epoxy steroids and intermediates useful therein'
[patent_app_type] => utility
[patent_app_number] => 10/647866
[patent_app_country] => US
[patent_app_date] => 2003-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 83006
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/887/06887991.pdf
[firstpage_image] =>[orig_patent_app_number] => 10647866
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/647866 | Processes for preparation of 9, 11-epoxy steroids and intermediates useful therein | Aug 24, 2003 | Issued |
| 90/006753 | USE OF TETRACYCLINE TO ENHANCE BONE PROTEIN SYNTHESIS AND/OR TREATMENT OF BONE DEFICIENCY | Aug 18, 2003 | Issued |
Array
(
[id] => 7470010
[patent_doc_number] => 20040054203
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-18
[patent_title] => 'Resin functionalization method'
[patent_app_type] => new
[patent_app_number] => 10/643361
[patent_app_country] => US
[patent_app_date] => 2003-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1887
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20040054203.pdf
[firstpage_image] =>[orig_patent_app_number] => 10643361
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/643361 | Resin functionalization method | Aug 18, 2003 | Abandoned |
| 90/006752 | INHIBITION OF MAMMALIAN COLLAGENOLYTIC ENZYMES BY TETRACYCLINES | Aug 17, 2003 | Issued |
Array
(
[id] => 7314347
[patent_doc_number] => 20040034002
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-19
[patent_title] => '3Alpha-hydroxy-3beta-methoxymethyl-substituted steroids and the use thereof'
[patent_app_type] => new
[patent_app_number] => 10/641073
[patent_app_country] => US
[patent_app_date] => 2003-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5379
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0034/20040034002.pdf
[firstpage_image] =>[orig_patent_app_number] => 10641073
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/641073 | 3Alpha-hydroxy-3beta-methoxymethyl-substituted steroids and the use thereof | Aug 14, 2003 | Abandoned |
Array
(
[id] => 439574
[patent_doc_number] => 07259180
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-08-21
[patent_title] => 'Methods and compositions for treatment of macular and retinal disease'
[patent_app_type] => utility
[patent_app_number] => 10/639972
[patent_app_country] => US
[patent_app_date] => 2003-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11142
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/259/07259180.pdf
[firstpage_image] =>[orig_patent_app_number] => 10639972
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/639972 | Methods and compositions for treatment of macular and retinal disease | Aug 12, 2003 | Issued |
Array
(
[id] => 7046153
[patent_doc_number] => 20050250748
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-10
[patent_title] => 'Combination therapy of angiotensin converting enzyme inhibitor and eplerenone for treatment of cardiovascular disease'
[patent_app_type] => utility
[patent_app_number] => 10/637070
[patent_app_country] => US
[patent_app_date] => 2003-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 39
[patent_no_of_words] => 37384
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0250/20050250748.pdf
[firstpage_image] =>[orig_patent_app_number] => 10637070
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/637070 | Combination therapy of angiotensin converting enzyme inhibitor and eplerenone for treatment of cardiovascular disease | Aug 5, 2003 | Abandoned |
Array
(
[id] => 7156036
[patent_doc_number] => 20050026891
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-03
[patent_title] => 'Progesterone receptor modulators with increased antigonadotropic activity for female birth control and hormone replacement therapy'
[patent_app_type] => utility
[patent_app_number] => 10/631967
[patent_app_country] => US
[patent_app_date] => 2003-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 13789
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0026/20050026891.pdf
[firstpage_image] =>[orig_patent_app_number] => 10631967
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/631967 | Progesterone receptor modulators with increased antigonadotropic activity for female birth control and hormone replacement therapy | Jul 31, 2003 | Issued |
Array
(
[id] => 7089685
[patent_doc_number] => 20050009798
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-13
[patent_title] => 'Carbonate and carbamate modified forms of glucocorticoids in combination with B2 adrenergic agonists'
[patent_app_type] => utility
[patent_app_number] => 10/633086
[patent_app_country] => US
[patent_app_date] => 2003-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5676
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20050009798.pdf
[firstpage_image] =>[orig_patent_app_number] => 10633086
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/633086 | Carbonate and carbamate modified forms of glucocorticoids in combination with B2 adrenergic agonists | Jul 31, 2003 | Abandoned |
Array
(
[id] => 169140
[patent_doc_number] => 07667056
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-02-23
[patent_title] => 'Process and new intermediates for the preparation of steroids with a progestogen activity'
[patent_app_type] => utility
[patent_app_number] => 10/523058
[patent_app_country] => US
[patent_app_date] => 2003-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6048
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/667/07667056.pdf
[firstpage_image] =>[orig_patent_app_number] => 10523058
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/523058 | Process and new intermediates for the preparation of steroids with a progestogen activity | Jul 30, 2003 | Issued |
Array
(
[id] => 5875258
[patent_doc_number] => 20060166954
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-27
[patent_title] => 'Polymorphis of a known thiophenecarboxylic acid dodecahydrocyclopenta (a) phenanthrenyl ester'
[patent_app_type] => utility
[patent_app_number] => 10/522358
[patent_app_country] => US
[patent_app_date] => 2003-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3510
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20060166954.pdf
[firstpage_image] =>[orig_patent_app_number] => 10522358
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/522358 | Polymorphis of a known thiophenecarboxylic acid dodecahydrocyclopenta (a) phenanthrenyl ester | Jul 27, 2003 | Issued |
Array
(
[id] => 7449214
[patent_doc_number] => 20040009962
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-15
[patent_title] => 'Combined estrogen blockade of the breast with exemestane and raloxifene'
[patent_app_type] => new
[patent_app_number] => 10/363244
[patent_app_country] => US
[patent_app_date] => 2003-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6123
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20040009962.pdf
[firstpage_image] =>[orig_patent_app_number] => 10363244
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/363244 | Combined estrogen blockade of the breast with exemestane and raloxifene | Jul 23, 2003 | Abandoned |
Array
(
[id] => 531733
[patent_doc_number] => 07179799
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-02-20
[patent_title] => '(3) and (6) substituted estrogenic compounds'
[patent_app_type] => utility
[patent_app_number] => 10/628057
[patent_app_country] => US
[patent_app_date] => 2003-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 47
[patent_figures_cnt] => 47
[patent_no_of_words] => 13466
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/179/07179799.pdf
[firstpage_image] =>[orig_patent_app_number] => 10628057
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/628057 | (3) and (6) substituted estrogenic compounds | Jul 22, 2003 | Issued |
Array
(
[id] => 651003
[patent_doc_number] => 07112580
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-09-26
[patent_title] => '3-nitrogen-6, 7-dioxygen steroids and uses related thereto'
[patent_app_type] => utility
[patent_app_number] => 10/624946
[patent_app_country] => US
[patent_app_date] => 2003-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 11
[patent_no_of_words] => 32760
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/112/07112580.pdf
[firstpage_image] =>[orig_patent_app_number] => 10624946
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/624946 | 3-nitrogen-6, 7-dioxygen steroids and uses related thereto | Jul 20, 2003 | Issued |
Array
(
[id] => 651003
[patent_doc_number] => 07112580
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-09-26
[patent_title] => '3-nitrogen-6, 7-dioxygen steroids and uses related thereto'
[patent_app_type] => utility
[patent_app_number] => 10/624946
[patent_app_country] => US
[patent_app_date] => 2003-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 11
[patent_no_of_words] => 32760
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/112/07112580.pdf
[firstpage_image] =>[orig_patent_app_number] => 10624946
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/624946 | 3-nitrogen-6, 7-dioxygen steroids and uses related thereto | Jul 20, 2003 | Issued |
Array
(
[id] => 7322497
[patent_doc_number] => 20040137050
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-15
[patent_title] => 'Linear polyethylenimine-sterol conjugates for gene delivery'
[patent_app_type] => new
[patent_app_number] => 10/623020
[patent_app_country] => US
[patent_app_date] => 2003-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 9661
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20040137050.pdf
[firstpage_image] =>[orig_patent_app_number] => 10623020
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/623020 | Linear polyethylenimine-sterol conjugates for gene delivery | Jul 16, 2003 | Issued |
Array
(
[id] => 62981
[patent_doc_number] => 07763600
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-07-27
[patent_title] => 'Hormone-based nitrogen monoxide donor compounds and use thereof in obstetrics and gynecology'
[patent_app_type] => utility
[patent_app_number] => 10/520637
[patent_app_country] => US
[patent_app_date] => 2003-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4939
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/763/07763600.pdf
[firstpage_image] =>[orig_patent_app_number] => 10520637
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/520637 | Hormone-based nitrogen monoxide donor compounds and use thereof in obstetrics and gynecology | Jul 8, 2003 | Issued |
